Back to results
US 2015/0148408 A1Published application
Heterocyclic modulators of cannabinoid receptors
AssigneeThe Cleveland Clinic Foundation
InventorsMohamed Naquib Attala, Philippe Diaz
Life of this patent
Estimating the term…
Abstract
Heterocyclic compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.
Claims3
-38. (canceled)
A method of modulating a cannabinoid receptor comprising contacting the cannabinoid receptor with a compound of formula structure I:
- or a salt, ester or prodrug thereof, wherein:
- R1 is selected from the group consisting of NH, NHR4, NR4R5, any carbon atom of which may be optionally substituted;
- R2 is selected from the group consisting of hydrogen, aryl, alkyl, cycloalkyl, aralkyl, alkenyl, and alkynyl, any carbon atom of which may be optionally substituted;
- R3 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl, any carbon atom of which may be optionally substituted;
- and
- R4 and R5 vary independently and are selected from the group consisting of aryl, alkyl, cycloalkyl, aralkyl, alkenyl, and alkynyl, any carbon atom of which may be optionally substituted.
3 more elements
Dependencies are inferred from the claim text.